Can self-rated health be useful to primary care physicians as a diagnostic indicator of metabolic dysregulations amongst patients with type 2 diabetes? A population-based study

Author:

Umeh Kanayo1,Adaji S2

Affiliation:

1. Liverpool John Moores University

2. Bousfield Health Centre

Abstract

Abstract

Background Although most of the management of type 2 diabetes (T2DM) occurs in primary care, and physicians are tasked with using a ‘whole person’ approach, there is currently a lack of research on psychosocial diagnostic indicators for detecting metabolic abnormalities in T2DM patients. This study examined relations between SRH and metabolic abnormalities in patients with type 2 diabetes, adjusting for metabolic comorbidity. Method A total of 583 adults with type 2 diabetes were identified from the 2019 HSE (Health Survey for England). Data on metabolic syndrome (MetS) was extracted, including lipids (high density lipoprotein cholesterol (HDL-C)), glycated haemoglobin (HbA1c), blood pressure (systolic/diastolic), and anthropometric measures (BMI, waist/hip ratio). Bootstrapped hierarchical regression and structural equation modelling (SEM) were used to analyse the data. Results Adjusting for metabolic covariates attenuated significant associations between SRH and metabolic abnormalities (HDL-C, HbA1c), regardless of MetS status. However, relations between SRH and HbA1c remained marginally significant, after metabolic adjustments (β = -0.15, p = 0.04). Analysis by gender uncovered covariate-adjusted associations between SRH and both HDL-C (in men) and HbA1c (in women) (p’s = 0.01). SEM revealed no indirect associations between SRH, metabolic abnormalities, and lifestyle factors. Conclusions SRH may help primary care physicians identify T2DM patients with HDL-C and HbA1c abnormalities, irrespective of comorbid metabolic biomarkers.

Publisher

Springer Science and Business Media LLC

Reference59 articles.

1. 2022 update to the position statement by Primary Care Diabetes Europe: a disease state approach to the pharmacological management of type 2 diabetes in primary care;Seidu S;Prim Care Diabetes,2022

2. The Global Epidemic of the Metabolic Syndrome;Saklayen MG;Curr Hypertens Rep,2018

3. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640-5.

4. Metabolic syndrome in type 2 diabetic patients: a review of current evidence;Regufe VMG;Porto Biomed J,2020

5. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds;Rochlani Y;Ther Adv Cardiovasc Dis,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3